SHC - Sotera Health Co Stock Price, Fair Value and News

11.29USD-0.12 (-1.05%)Market Closed

Market Summary

USD11.29-0.12

Market Closed

-1.05%

SHC Stock Price

View Fullscreen

SHC RSI Chart

SHC Valuation

Market Cap

3.2B

Price/Earnings (Trailing)

62.21

Price/Sales (Trailing)

2.97

EV/EBITDA

13.01

Price/Free Cashflow

-8.48

SHC Price/Sales (Trailing)

SHC Profitability

Operating Margin

55.05%

EBT Margin

10.37%

Return on Equity

11.96%

Return on Assets

1.68%

Free Cashflow Yield

-11.79%

SHC Fundamentals

SHC Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

12.51%

Rev. Growth (Qtr)

-20%

SHC Earnings

Earnings (TTM)

51.4M

Earnings Growth (Yr)

112.1%

Earnings Growth (Qtr)

383.17%

Breaking Down SHC Revenue

Last 7 days

2.3%

Last 30 days

5.0%

Last 90 days

-32.0%

Trailing 12 Months

-25.0%

How does SHC drawdown profile look like?

SHC Financial Health

Current Ratio

3.2

Debt/Equity

5.18

Debt/Cashflow

-0.08

SHC Investor Care

Shares Dilution (1Y)

0.20%

Diluted EPS (TTM)

0.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1B	0	0	0
2023	987.5M	976.2M	990.6M	1.0B
2022	956.1M	970.8M	993.3M	1.0B
2021	842.1M	880.9M	907.1M	931.5M
2020	788.3M	798.2M	808.2M	818.2M
2019	0	0	0	778.3M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Sotera Health Co

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 04, 2024	rutz michael p	acquired	-	-	34,270	president of sterigenics
Mar 04, 2024	gtcr investment xi llc	sold	-158,283,000	14.3075	-11,062,900	-
Mar 04, 2024	petras michael b. jr.	sold	-14,362,900	14.3075	-1,003,870	chairman & ceo
Mar 04, 2024	klee ann r.	sold	-82,268	14.3075	-5,750	-
Mar 04, 2024	lyons jonathan m.	acquired	-	-	41,124	sr. vice president, cfo
Mar 04, 2024	warburg pincus & co.	sold	-237,424,000	14.3075	-16,594,400	-
Mar 04, 2024	petras michael b. jr.	acquired	-	-	274,160	chairman & ceo
Mar 04, 2024	rutz michael p	sold	-1,189,080	14.3075	-83,109	president of sterigenics
Mar 04, 2024	dimitrief alexander	acquired	-	-	51,405	svp, general counsel and sec.
Mar 02, 2024	petras michael b. jr.	sold (taxes)	-721,652	14.56	-49,564	chairman & ceo

Which funds bought or sold SHC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	added	606	3,381,580	4,219,090	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-2.83	-541,204	1,219,270	-%
May 16, 2024	COMERICA BANK	added	20.13	-97,140	578,629	-%
May 16, 2024	Wiser Advisor Group LLC	unchanged	-	-484	1,202	-%
May 16, 2024	Pineridge Advisors LLC	reduced	-90.92	-21,180	1,466	-%
May 15, 2024	Royal Bank of Canada	reduced	-85.61	-817,000	93,000	-%
May 15, 2024	T. Rowe Price Investment Management, Inc.	added	40.22	-33,000	60,493,000	0.04%
May 15, 2024	Tower Research Capital LLC (TRC)	added	60.22	15,393	123,823	-%
May 15, 2024	LAKEWOOD CAPITAL MANAGEMENT, LP	new	-	27,715,900	27,715,900	2.26%
May 15, 2024	DME Capital Management, LP	new	-	3,604,320	3,604,320	0.16%

Are Funds Buying or Selling SHC?

Are funds buying SHC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SHC

No. of Funds

Unveiling Sotera Health Co's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2022	warburg pincus & co.	62.1%	175,695,524	SC 13G/A
Feb 11, 2022	gtcr investment xi llc	62.1%	175,695,524	SC 13G/A

Recent SEC filings of Sotera Health Co

View All Filings

Date Filed	Form Type	Document
May 16, 2024	8-K	Current Report
May 08, 2024	DEFR14A	DEFR14A
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
May 02, 2024	8-K/A	Current Report
Apr 11, 2024	ARS	ARS
Apr 11, 2024	DEF 14A	DEF 14A
Apr 11, 2024	DEFA14A	DEFA14A
Mar 22, 2024	PRE 14A	PRE 14A
Mar 06, 2024	4	Insider Trading

Peers (Alternatives to Sotera Health Co)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	196.9B	23.7B	11.04%	17.40%	44.73	8.29	-8.94%	-35.91%
A	45.2B	6.7B	14.64%	19.44%	36.57	6.71	-2.81%	-6.58%
IDXX	44.9B	3.7B	13.71%	10.52%	51.83	12.06	8.57%	23.94%
DGX	16.0B	9.3B	13.66%	10.24%	18.95	1.73	-3.29%	6.68%
NTRA	13.1B	1.2B	17.80%	114.36%	-35.76	10.81	39.26%	33.08%
MEDP	12.2B	2.0B	2.71%	87.82%	38.94	6.2	25.57%	21.62%
CRL	11.4B	4.1B	-3.66%	11.24%	26.02	2.78	0.49%	-11.59%
EXAS	9.3B	2.5B	-20.33%	-38.03%	-38.69	3.67	15.21%	53.51%
MID-CAP
GH	3.1B	603.7M	54.73%	-14.09%	-6.73	5.14	25.21%	30.68%
NEOG	2.9B	929.2M	11.70%	-18.80%	1.9K	3.16	28.93%	111.61%
SMALL-CAP
CDNA	808.3M	275.1M	87.44%	103.94%	-4.41	2.94	-13.93%	-126.97%
ACRS	84.8M	31.1M	-3.25%	-85.34%	-1.1	2.73	0.95%	19.75%
AWH	33.0M	9.2M	-24.07%	-37.65%	-2.24	3.6	11.85%	45.80%
APDN	2.5M	5.5M	-62.31%	120.18%	-0.2	0.45	-68.52%	-141.15%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Sotera Health Co News

Latest updates

Sotera Health Co Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																		(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	-20.0%	248	310	263	255	221	252	249	267	237	241	226	252	212	217	200	213	188	-
Cost Of Revenue	-7.0%	121	130	117	116	109	110	113	116	108	107	101	108	97.00	96.00	93.00	94.00	92.00	-
Gross Profit	-29.4%	127	180	146	140	112	142	136	150	129	134	126	144	115	121	108	119	97.00	-
Operating Expenses	-2.8%	74.00	76.00	70.00	76.00	78.00	82.00	73.00	79.00	75.00	68.00	60.00	65.00	69.00	68.00	60.00	57.00	52.00	-
S&GA Expenses	-3.6%	58.00	60.00	54.00	60.00	62.00	66.00	57.00	63.00	60.00	52.00	44.00	50.00	52.00	53.00	46.00	43.00	37.00	-
EBITDA Margin	8.3%	0.37*	0.34*	-0.11*	-0.12*	-0.12*	-0.10*	0.33*	0.33*	0.34*	0.32*	0.27*	0.27*	-	-	-	-	-	-
Interest Expenses	201.3%	70.00	23.00	72.00	43.00	35.00	11.00	23.00	26.00	16.00	5.00	17.00	17.00	20.00	47.00	51.00	49.00	64.00	-
Income Taxes	-82.6%	5.00	27.00	14.00	11.00	3.00	-58.78	17.00	18.00	15.00	23.00	14.00	19.00	3.00	8.00	-1.21	4.00	-12.23	-
Earnings Before Taxes	-83.2%	11.00	66.00	0.00	34.00	5.00	-378	42.00	48.00	45.00	59.00	41.00	62.00	14.00	-35.08	-0.58	11.00	-14.22	-
EBT Margin	2.6%	0.10*	0.10*	-0.34*	-0.30*	-0.29*	-0.24*	0.20*	0.20*	0.22*	0.19*	0.09*	0.05*	-	-	-	-	-	-
Net Income	-100.0%	-	39.00	-13.66	24.00	3.00	-319	25.00	30.00	31.00	36.00	27.00	43.00	11.00	-43.68	0.00	7.00	-1.96	-
Net Income Margin	-2.6%	0.05*	0.05*	-0.31*	-0.27*	-0.26*	-0.23*	0.12*	0.13*	0.14*	0.13*	0.04*	0.01*	-	-	-	-	-	-
Free Cashflow	-152.2%	-25.19	48.00	-10.17	-389	-11.13	30.00	29.00	22.00	14.00	25.00	65.00	54.00	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	-2.3%	3,060	3,130	3,037	3,075	3,414	3,118	2,811	2,840	2,836	2,790	2,743	2,851	2,777	2,761
Current Assets	-12.6%	487	557	520	547	924	645	421	399	372	346	337	401	328	315
Cash Equivalents	-11.3%	263	296	245	263	648	395	165	141	121	107	115	156	108	102
Inventory	6.3%	51.00	48.00	38.00	42.00	47.00	37.00	37.00	40.00	46.00	54.00	37.00	36.00	33.00	34.00
Net PPE	-	-	-	884	-	-	775	704	700	669	651	624	624	612	610
Goodwill	-0.8%	1,103	1,111	1,101	1,110	1,103	1,102	1,092	1,116	1,126	1,120	1,103	1,114	1,107	1,116
Liabilities	-2.1%	2,630	2,687	2,659	2,657	3,053	2,767	2,204	2,204	2,194	2,203	2,217	2,328	2,311	2,307
Current Liabilities	-34.0%	152	231	201	200	600	792	140	142	144	161	134	149	138	141
Long Term Debt	0.0%	2,225	2,224	2,223	2,222	2,222	1,747	1,747	1,746	1,745	1,744	1,743	1,838	1,838	1,825
LT Debt, Current	0.2%	5.00	5.00	5.00	5.00	4.00	197	-	-	-	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	2,224	2,223	2,222	2,222	1,747	-	-	1,745	1,744	-	-	1,838	1,825
Shareholder's Equity	-3.2%	429	444	377	418	361	350	607	636	642	586	526	523	466	455
Retained Earnings	1.0%	-648	-654	-693	-679	-702	-705	-386	-411	-441	-472	-508	-535	-578	-589
Additional Paid-In Capital	0.4%	1,221	1,215	1,210	1,203	1,195	1,190	1,187	1,182	1,177	1,173	1,171	1,168	1,170	1,166
Shares Outstanding	0.3%	282	281	281	281	281	280	280	280	280	279	279	279	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	2.00	2.00
Float	-	-	-	-	1,871	-	-	-	1,948	-	-	-	2,403	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																		(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	-91.4%	9,699	113,123	41,849	-336,575	33,871	101,926	67,779	58,289	49,967	66,351	80,938	78,097	56,159	21,845	46,053	46,997	5,690	-
Share Based Compensation	5.6%	8,663	8,204	8,378	8,373	7,288	6,256	4,616	5,801	4,538	3,381	3,547	3,493	3,449	6,968	901	1,393	1,725	-
Cashflow From Investing	46.2%	-34,853	-64,826	-51,978	-53,134	-44,968	-71,738	-38,966	-35,709	-35,483	-72,263	-16,596	-24,455	-46,519	-18,774	-116,482	-10,449	-12,989	-
Cashflow From Financing	-214.8%	-11,941	-3,793	-3,454	-710	273,916	199,244	-400	-634	-449	-1,782	-103,414	-8,307	-3,783	-10,529	90,479	-55,825	49,307	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

SHC Income Statement

2024-03-31

Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total net revenues	$ 248,176	$ 220,590
Cost of revenues:
Total cost of revenues	121,061	109,087
Gross profit	127,115	111,503
Operating expenses:
Selling, general and administrative expenses	58,209	61,910
Amortization of intangible assets	15,732	16,227
Total operating expenses	73,941	78,137
Operating income	53,174	33,366
Interest expense, net	41,771	28,870
Foreign exchange (gain) loss	(572)	347
Other expense (income), net	961	(1,253)
Income before income taxes	11,014	5,402
Provision for income taxes	4,691	2,560
Net income	6,323	2,842
Other comprehensive income (loss) net of tax:
Pension and post-retirement benefits (net of taxes of $37 and $(17), respectively)	113	(51)
Interest rate derivatives (net of taxes of $146 and $(3,396), respectively)	419	(9,251)
Foreign currency translation	(27,706)	11,257
Comprehensive (loss) income	$ (20,851)	$ 4,797
Earnings per share:
Basic (in dollars per share)	$ 0.02	$ 0.01
Diluted (in dollars per share)	$ 0.02	$ 0.01
Weighted average number of shares outstanding:
Basic (in shares)	281,913	280,691
Diluted (in shares)	284,062	282,977
Service
Revenues:
Total net revenues	$ 226,481	$ 214,510
Cost of revenues:
Total cost of revenues	110,852	104,210
Product
Revenues:
Total net revenues	21,695	6,080
Cost of revenues:
Total cost of revenues	$ 10,209	$ 4,877

SHC Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 261,133	$ 296,407
Restricted cash short-term	1,687	5,247
Accounts receivable, net of allowance for uncollectible accounts of $3,925 and $4,689, respectively	111,069	147,696
Inventories, net	51,342	48,316
Prepaid expenses and other current assets	53,663	53,846
Income taxes receivable	8,285	5,732
Total current assets	487,179	557,244
Property, plant, and equipment, net	979,422	946,914
Operating lease assets	22,517	24,037
Deferred income taxes	4,883	4,993
Post-retirement assets	29,502	28,482
Other assets	42,881	41,242
Other intangible assets, net	390,457	416,318
Goodwill	1,102,851	1,111,190
Total assets	3,059,692	3,130,420
Current liabilities:
Accounts payable	61,576	71,039
Accrued liabilities	61,774	122,471
Deferred revenue	12,882	13,492
Current portion of long-term debt	4,808	4,797
Current portion of finance lease obligations	1,490	8,771
Current portion of operating lease obligations	5,303	5,934
Income taxes payable	4,507	4,150
Total current liabilities	152,340	230,654
Long-term debt, less current portion	2,224,611	2,223,674
Finance lease obligations, less current portion	90,858	63,793
Operating lease obligations, less current portion	19,132	20,087
Noncurrent asset retirement obligations	48,021	47,944
Deferred lease income	18,223	18,762
Post-retirement obligations	8,235	8,439
Noncurrent liabilities	8,728	8,879
Deferred income taxes	60,152	64,454
Total liabilities	2,630,300	2,686,686
See Commitments and contingencies note
Equity:
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 shares issued at March 31, 2024 and December 31, 2023	2,860	2,860
Preferred stock, with $0.01 par value, 120,000 authorized; no shares issued at March 31, 2024 and December 31, 2023	0	0
Treasury stock, at cost (2,966 and 3,207 shares at March 31, 2024 and December 31, 2023, respectively)	(26,042)	(27,182)
Additional paid-in capital	1,220,547	1,215,178
Retained deficit	(648,117)	(654,440)
Accumulated other comprehensive loss	(119,856)	(92,682)
Total equity	429,392	443,734
Total liabilities and equity	$ 3,059,692	$ 3,130,420

About Sotera Health Co

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services. The company serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

CEO	Mr. Michael B. Petras Jr.
WEBSITE	https://soterahealth.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	3000

Sotera Health Co Frequently Asked Questions

What is the ticker symbol for Sotera Health Co? What does SHC stand for in stocks?

SHC is the stock ticker symbol of Sotera Health Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sotera Health Co (SHC)?

As of Fri May 17 2024, market cap of Sotera Health Co is 3.2 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SHC stock?

You can check SHC's fair value in chart for subscribers.

What is the fair value of SHC stock?

You can check SHC's fair value in chart for subscribers. The fair value of Sotera Health Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Sotera Health Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Sotera Health Co a good stock to buy?

The fair value guage provides a quick view whether SHC is over valued or under valued. Whether Sotera Health Co is cheap or expensive depends on the assumptions which impact Sotera Health Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SHC.

What is Sotera Health Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, SHC's PE ratio (Price to Earnings) is 62.21 and Price to Sales (PS) ratio is 2.97. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SHC PE ratio will change depending on the future growth rate expectations of investors.